MS patients are in sustained remission after stem cell transplantation, small study findsBMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g7832 (Published 30 December 2014) Cite this as: BMJ 2014;349:g7832
- Susan Mayor
Most patients with relapsing remitting multiple sclerosis (MS) who are taking part in a small study of high dose immunosuppressive therapy followed by transplantation of their own haematopoietic stem cells have experienced sustained remission for three years, a study has found.
The ongoing study includes 25 MS patients who had experienced relapses with loss of neurologic function while on disease modifying therapies during the 18 months before recruitment. They …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial